Pinebridge Investments L.P. Cuts Stock Position in DaVita Inc. (NYSE:DVA)

Pinebridge Investments L.P. decreased its stake in shares of DaVita Inc. (NYSE:DVA) by 6.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 104,294 shares of the company’s stock after selling 7,622 shares during the quarter. Pinebridge Investments L.P. owned about 0.13% of DaVita worth $15,597,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in DVA. Hsbc Holdings PLC raised its position in shares of DaVita by 110.5% in the 4th quarter. Hsbc Holdings PLC now owns 153,838 shares of the company’s stock worth $23,012,000 after purchasing an additional 80,750 shares during the last quarter. Stifel Financial Corp raised its holdings in DaVita by 3.2% in the fourth quarter. Stifel Financial Corp now owns 5,937 shares of the company’s stock worth $888,000 after buying an additional 185 shares during the last quarter. TD Waterhouse Canada Inc. lifted its stake in shares of DaVita by 179.5% in the fourth quarter. TD Waterhouse Canada Inc. now owns 981 shares of the company’s stock worth $147,000 after buying an additional 630 shares in the last quarter. Natixis purchased a new stake in shares of DaVita during the fourth quarter valued at approximately $1,701,000. Finally, Norinchukin Bank The increased its position in shares of DaVita by 9.4% during the fourth quarter. Norinchukin Bank The now owns 2,113 shares of the company’s stock valued at $316,000 after acquiring an additional 182 shares in the last quarter. 90.12% of the stock is owned by institutional investors.

DaVita Trading Up 3.0 %

DaVita stock opened at $139.08 on Thursday. The business has a 50-day simple moving average of $147.16 and a two-hundred day simple moving average of $155.53. DaVita Inc. has a 52-week low of $130.96 and a 52-week high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The company has a market cap of $11.13 billion, a P/E ratio of 12.95, a P/E/G ratio of 1.07 and a beta of 1.04.

DaVita (NYSE:DVA) last announced its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Wall Street Analysts Forecast Growth

DVA has been the topic of several recent analyst reports. Sanford C. Bernstein set a $184.00 target price on DaVita in a research note on Friday, February 21st. StockNews.com raised DaVita from a “hold” rating to a “buy” rating in a research report on Thursday, April 10th. Barclays boosted their target price on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. Finally, Cowen reaffirmed a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.